Distinct roles of estrogen receptor-α and β in the modulation of vascular inducible nitric-oxide synthase in diabetes

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 1, 2009, Pages 174-182

  Cignarella, Andrea ^a,b   Bolego, Chiara ^a,b   Pelosi, Valeria ^a,b   Meda, Clara ^b   Krust, Andrée ^c   Pinna, Christian ^b   Gaion, Rosa Maria ^a   Vegeto, Elisabetta ^b   Maggi, Adriana ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4,4',4'' (4 PROPYL[1H]PYRAZOLE 1,3,5 TRIYL)TRISPHENOL; DIARYLPROPIONITRILE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STREPTOZOCIN; UNCLASSIFIED DRUG; 1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; NITRILE; NITRITE; PROPIONIC ACID DERIVATIVE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; HYPERGLYCEMIA; KNOCKOUT MOUSE; LIGAND BINDING; MALE; NONHUMAN; OVARY INFLAMMATION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULARIZATION; VASCULITIS; ANIMAL; AORTA; BIOSYNTHESIS; C57BL MOUSE; ENZYME INDUCTION; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENETIC TRANSFECTION; GENETICS; INFLAMMATION; METABOLISM; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; DIABETES MELLITUS, EXPERIMENTAL; ENZYME INDUCTION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE II; NITRILES; NITRITES; PROPIONATES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION;

EID: 59149095338     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.143511     Document Type: Article

References (41)

1. Ardelt AA, McCullough LD, Korach KS, Wang MM, Munzenmaier DH, and Hurn PD (2005) Estradiol regulates angiopoietin-1 mRNA expression through estrogen re-ceptor-α in a rodent experimental stroke model. Stroke 36:337-341.
2. Baker AE, Brautigam VM, and Watters JJ (2004) Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor β. Endocrinology 145:5021-5032.
3. Bardell AL and MacLeod KM (2001) Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J Pharmacol Exp Ther 296:252-259.
4. Barros RP, Machado UF, and Gustafsson JA (2006) Estrogen receptors: new players in diabetes mellitus. Trends Mol Med 12:425-431.
5. Barros RP, Machado UF, Warner M, and Gustafsson JA (2006) Muscle GLUT4 regulation by estrogen receptors ERβ and ERα. Proc Natl Acad Sci U S A 103: 1605-1608.
6. Binko J and Majewski H (1998) 17β-estradiol reduces vasoconstriction in endothe-lium-denuded rat aortas through inducible NOS. Am J Physiol 274:H853-H859.
7. Bolego C, Cignarella A, Sanvito P, Pelosi V, Pellegatta F, Puglisi L, and Pinna C (2005) The acute estrogenic dilation of rat aorta is mediated solely by selective estrogen receptor-α agonists and is abolished by estrogen deprivation. J Pharmacol Exp Ther 313:1203-1208.
8. Bolego C, Vegeto E, Pinna C, Maggi A, and Cignarella A (2006) Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease. Arterio-scler Thromb Vasc Biol 26:2192-2199.
9. Bryzgalova G, Gao H, Ahren B, Zierath JR, Galuska D, Steiler TL, Dahlman-Wright K, Nilsson S, Gustafsson JA, Efendic S, et al. (2006) Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 49:588-597.
10. Cao G, Liang Y, Broderick CL, Oldham BA, Beyer TP, Schmidt RJ, Zhang Y, Stayrook KR, Suen C, Otto KA, et al. (2003) Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem 278:1131-1136.
11. Ciana P, Di Luccio G, Belcredito S, Pollio G, Vegeto E, Tatangelo L, Tiveron C, and Maggi A (2001) Engineering of a mouse for the in vivo profiling of estrogen receptor activity. Mol Endocrinol 15:1104-1113.
12. Cignarella A, Minici C, Bolego C, Pinna C, Sanvito P, Gaion RM, and Puglisi L (2006) Potential pro-inflammatory action of resveratrol in vascular smooth muscle cells from normal and diabetic rats. Nutr Metab Cardiovasc Dis 16:322-329.
13. Darblade B, Pendaries C, Krust A, Dupont S, Fouque MJ, Rami J, Chambon P, Bayard F, and Arnal JF (2002) Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor. Circ Res 90:413-419.
14. Deroo BJ and Korach KS (2006) Estrogen receptors and human disease. J Clin Invest 116:561-570.
15. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, and Mark M (2000) Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ)on mouse reproductive phenotypes. Development 127:4277-4291.
16. Ghisletti S, Meda C, Maggi A, and Vegeto E (2005) 17β-estradiol inhibits inflammatory gene expression by controlling NF-κB intracellular localization. Mol Cell Biol 25:2957-2968.
17. Haas E, Meyer MR, Schurr U, Bhattacharya I, Minotti R, Nguyen HH, Heigl A, Lachat M, Genoni M, and Barton M (2007) Differential effects of 17β-estradiol on function and expression of estrogen receptor α, estrogen receptor β, and GPR30 in arteries and veins of patients with atherosclerosis. Hypertension 49:1358-1363.
18. Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, and Kat-zenellenbogen BS (2003) Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 206:13-22.
19. Harris HA (2007) Estrogen receptor-β: recent lessons from in vivo studies. Mol Endocrinol 21:1-13.
20. Idel S, Ellinghaus P, Wolfrum C, Nofer JR, Gloerich J, Assmann G, Spener F, and Seedorf U (2002) Branched chain fatty acids induce nitric oxide-dependent apop-tosis in vascular smooth muscle cells. J Biol Chem 277:49319-49325.
21. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
22. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E; Heart and Estrogen/progestin Replacement Study (2003) Gly-cemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 138:1-9.
23. Kauser K, Sonnenberg D, Diel P, and Rubanyi GM (1998) Effect of 17β-oestradiol on cytokine-induced nitric oxide production in rat isolated aorta. Br J Pharmacol 123:1089-1096.
24. Laffitte BA, Chao LC, Li J, Walczak R, Hummasti S, Joseph SB, Castrillo A, Wilpitz DC, Mangelsdorf DJ, Collins JL, et al. (2003) Activation of liver X receptor improves glucose tolerance through coordinate regulation ofglucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A 100:5419-5424.
25. Le May C, Chu K, Hu M, Ortega CS, Simpson ER, Korach KS, Tsai MJ, and Mauvais-Jarvis F (2006) Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci U S A 103:9232-9237.
26. Liang M, Ekblad E, Lydrup ML, and Nilsson BO (2003) Combined lack of estrogen receptors α and β affects vascular iNOS protein expression. Cell Tissue Res 313:63-70.
27. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, and Mendelsohn ME (1998) Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res 83:224-229.
28. Maggi A, Cignarella A, Brusadelli A, Bolego C, Pinna C, and Puglisi L (2003) Diabetes undermines estrogen control of inducible nitric oxide synthase function in rat aortic smooth muscle cells through overexpression of estrogen receptor-β. Circulation 108:211-217.
29. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, and Howard BV; Women's Health Initiative Investigators (2004) Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Dia-betologia 47:1175-1187.
30. Marriott LK, McGann-Gramling KR, Hauss-Wegrzyniak B, Sheldahl LC, Shapiro RA, Dorsa DM, and Wenk GL (2007) Brain infusion of lipopolysaccharide increases uterine growth as a function of estrogen replacement regimen: suppression of uterine estrogen receptor-α by constant, but not pulsed, estrogen replacement. Endocrinology 148:232-240.
31. Nagareddy PR, Xia Z, McNeill JH, and MacLeod KM (2005) Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 289:H2144-H2152.
32. O'Lone R, Knorr K, Jaffe IZ, Schaffer ME, Martini PG, Karas RH, Bienkowska J, Mendelsohn ME, and Hansen U (2007) Estrogen receptors a and β mediate distinct pathways of vascular gene expression, including genes involved in mitochondrial electron transport and generation of reactive oxygen species. Mol Endocrinol 21:1281-1296.
33. Pettersson K, Grandien K, Kuiper GG, and Gustafsson JA (1997) Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 11:1486-1496.
34. Pinna C, Cignarella A, Sanvito P, Pelosi V, and Bolego C (2008) Prolonged ovarian hormone deprivation impairs the protective vascular actions of estrogen receptor α agonists. Hypertension 51:1210-1217.
35. Romero MJ, Platt DH, Tawfik HE, Labazi M, El-Remessy AB, Bartoli M, Caldwell RB, and Caldwell RW (2008) Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 102:95-102.
36. Siow RC, Li FY, Rowlands DJ, de Winter P, and Mann GE (2007) Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic Biol Med 42:909-925.
37. Traish AM, Kim NN, Huang YH, Min K, Munarriz R, and Goldstein I (2003) Sex steroid hormones differentially regulate nitric oxide synthase and arginase activities in the proximal and distal rabbit vagina. Int J Impot Res 15:397-404.
38. Vegeto E, Belcredito S, Etteri S, Ghisletti S, Brusadelli A, Meda C, Krust A, Dupont S, Ciana P, Chambon P, et al. (2003) Estrogen receptor-α mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A 100:9614-9619.
39. Zancan V, Santagati S, Bolego C, Vegeto E, Maggi A, and Puglisi L (1999) 17β-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells. Endocrinology 140:2004-2009.
40. Zhang Y, Lee FY, Barrera G, Lee H, Vales C, Gonzalez FJ, Willson TM, and Edwards PA (2006) Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice. Proc Natl Acad Sci U S A 103:1006-1011.
41. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, et al. (2002) Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science 295:505-508.